Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Perioperative Sleep Quality in Brain Tumor Surgery
NCT07903051Phase 2Not yet recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Nov 2026
- Primary completion
- Dec 2027
01
Overview
Phase 2, randomised, double-blind trial in insomnia disorder comparing Lemborexant 5 mg with Placebo (2 arms). Primary endpoint: Total Sleep Time. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
lemborexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT07903051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07903051.